Literature DB >> 26120900

Interaction of methamphetamine abuse, tobacco abuse, and gender in the brain.

Joseph O'Neill1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26120900      PMCID： PMC4604441          DOI： 10.3109/00952990.2015.1043439

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN： 0095-2990            Impact factor:   3.829


× No keyword cloud information.
  11 in total

1.  Comorbid psychiatric disorders, sex, and methamphetamine use in adolescents: a case-control study.

Authors:  Cheng-Fang Yen; Mian-Yoon Chong
Journal:  Compr Psychiatry       Date:  2006 May-Jun       Impact factor: 3.735

2.  Gender differences in the effect of tobacco use on brain phosphocreatine levels in methamphetamine-dependent subjects.

Authors:  Young-Hoon Sung; Deborah A Yurgelun-Todd; Douglas G Kondo; Xian-Feng Shi; Kelly J Lundberg; Tracy L Hellem; Rebekah S Huber; Erin C McGlade; Eun-Kee Jeong; Perry F Renshaw
Journal:  Am J Drug Alcohol Abuse       Date:  2015-04-14       Impact factor: 3.829

Review 3.  Epidemiology and etiology of Parkinson's disease: a review of the evidence.

Authors:  Karin Wirdefeldt; Hans-Olov Adami; Philip Cole; Dimitrios Trichopoulos; Jack Mandel
Journal:  Eur J Epidemiol       Date:  2011-05-28       Impact factor: 8.082

Review 4.  Smoking and increased Alzheimer's disease risk: a review of potential mechanisms.

Authors:  Timothy C Durazzo; Niklas Mattsson; Michael W Weiner
Journal:  Alzheimers Dement       Date:  2014-06       Impact factor: 21.566

5.  Cingulate function in depression: a potential predictor of treatment response.

Authors:  H S Mayberg; S K Brannan; R K Mahurin; P A Jerabek; J S Brickman; J L Tekell; J A Silva; S McGinnis; T G Glass; C C Martin; P T Fox
Journal:  Neuroreport       Date:  1997-03-03       Impact factor: 1.837

6.  Evidence against the operation of selective mortality in explaining the association between cigarette smoking and reduced occurrence of idiopathic Parkinson disease.

Authors:  D M Morens; A Grandinetti; J W Davis; G W Ross; L R White; D Reed
Journal:  Am J Epidemiol       Date:  1996-08-15       Impact factor: 4.897

7.  Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake.

Authors:  Harvey Checkoway; Karen Powers; Terri Smith-Weller; Gary M Franklin; W T Longstreth; Phillip D Swanson
Journal:  Am J Epidemiol       Date:  2002-04-15       Impact factor: 4.897

8.  Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder.

Authors:  Jakub Z Konarski; Sidney H Kennedy; Zindel V Segal; Mark A Lau; Peter J Bieling; Roger S McIntyre; Helen S Mayberg
Journal:  J Psychiatry Neurosci       Date:  2009-05       Impact factor: 6.186

Review 9.  Smoking and Alzheimer's disease: a review of the epidemiological evidence.

Authors:  P N Lee
Journal:  Neuroepidemiology       Date:  1994       Impact factor: 3.282

10.  Decreased frontal lobe phosphocreatine levels in methamphetamine users.

Authors:  Young-Hoon Sung; Deborah A Yurgelun-Todd; Xian-Feng Shi; Douglas G Kondo; Kelly J Lundberg; Erin C McGlade; Tracy L Hellem; Rebekah S Huber; Kristen K Fiedler; Renee E Harrell; Bethany R Nickerson; Seong-Eun Kim; Eun-Kee Jeong; Perry F Renshaw
Journal:  Drug Alcohol Depend       Date:  2012-10-18       Impact factor: 4.492
View more
  1 in total

Review 1.  Mechanisms and genetic factors underlying co-use of nicotine and alcohol or other drugs of abuse.

Authors:  Sarah J Cross; Shahrdad Lotfipour; Frances M Leslie
Journal:  Am J Drug Alcohol Abuse       Date:  2016-08-17       Impact factor: 3.829
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.